Job Trends
Regeneron continues to expand its presence in New York. Over the next six years, the company will invest approximately $1.8 billion to expand its Tarrytown facilities. The investment will support the addition of 1,000 new jobs.
Labor Market Reports
BioSpace’s Q3 2025 U.S. Life Sciences Job Market Report reveals a turbulent quarter for biopharma hiring, with record declines in job postings, rising layoffs, and cautious employer sentiment shaping the industry’s employment landscape.
BioSpace data show biopharma professionals faced increased competition for fewer employment opportunities during the second quarter of 2025, with increased pressure from further layoffs.
Establishing trust through thought leadership is no longer optional in today’s cautious biopharma market. Learn how strategic insights and targeted outreach can turn awareness into high-converting leads.
Now Hiring
Of the 25 companies receiving tax incentives in Massachusetts, 23 will add jobs outside of Boston and Cambridge. Medtronic, which is receiving the largest award, will create 220 roles in Billerica. Other recipients include AbbVie, Dyne Therapeutics and Viridian Therapeutics.
Looking for a job in regulatory? Check out the BioSpace list of eight companies hiring life sciences professionals like you.
Looking for a job in oncology? Check out the BioSpace list of nine companies hiring life sciences professionals like you.
THE LATEST
MassBio recently published their annual “2019 Industry Snapshot.” In addition to providing an in-depth look at the industry in the state, it provides a wealth of data on the industry overall.
Kalos Therapeutics has engaged with The OCMX to assist in fund raising.
Between J&J, Purdue ($270 million), and Israel-based Teva Pharmaceuticals ($85 million), Oklahoma will garner about $927 million – a far cry from the $20 billion the state had been seeking in damages related to the opioid crisis.
Denver Health Foundation has been awarded a grant from The Gerber Foundation to fund a research project, the NO TEARS study, looking at ear infections, the most common childhood infection.
Study will evaluate outcomes from integrating oral health care with community health center services
More Women May Benefit from Hereditary Cancer Risk Assessment and Genetic Testing
rfxcel, the global leader in supply chain track and trace solutions, will exhibit at this year’s CPhI Middle East & Africa conference in Abu Dhabi, United Arab Emirates.
The National Institutes of Health has awarded Fannin Innovation Studio® a $1 million grant to continue development of PM-43I, the company’s anti-asthma drug, in collaboration with portfolio company Atrapos Therapeutics, LLC., as a more effective alternative to steroids.
“This investment will further strengthen Pfizer’s leadership in gene therapy manufacturing technology,” stated Mike McDermott, president, Pfizer Global Supply.
Merck’s checkpoint inhibitor Keytruda (pembrolizumab) has been approved for 21 indications, but you’d better keep up, because it seems the drug is approved for some new indication or combination just about every week.